BioCentury | Jul 9, 2020
Finance

July 8 Quick Takes: CapitalBio raises $113M, plans Shanghai IPO; plus Aidea, CF PharmTech, Denovo, Nucleai and Vaxdyn

...efficacy biomarkers to support clinical oncology and neurology trials. Nucleai raises $6.5 million series A Nucleai...
...the first Spanish biotech to receive CARB-X funding. Hongjiang Li, Staff Writer CapitalBio Corp. CF PharmTech Inc. Denovo Biopharma LLC Nucleai Jiangsu...
Items per page:
1 - 1 of 1
BioCentury | Jul 9, 2020
Finance

July 8 Quick Takes: CapitalBio raises $113M, plans Shanghai IPO; plus Aidea, CF PharmTech, Denovo, Nucleai and Vaxdyn

...efficacy biomarkers to support clinical oncology and neurology trials. Nucleai raises $6.5 million series A Nucleai...
...the first Spanish biotech to receive CARB-X funding. Hongjiang Li, Staff Writer CapitalBio Corp. CF PharmTech Inc. Denovo Biopharma LLC Nucleai Jiangsu...
Items per page:
1 - 1 of 1